drugset / Trial / NCT00911235
The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study is designed to estimate the effect of fluconazole (200 mg BID for 2 days), a moderate CYP3A4 inhibitor on the pharmacokinetics of a single 8 mg oral dose of fesoterodine in healthy adult subjects.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fesoterodine | Other / unclassified | 8 mg | Oral |
| Subject | Fluconazole | Small molecule | 200 mg | Oral |